BeiGene

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BeiGene and other ETFs, options, and stocks.

About ONC

BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. 

CEO
John V. Oyler
CEOJohn V. Oyler
Employees
11,000
Employees11,000
Headquarters
Basel, Basel-Landschaft (Basle Country)
HeadquartersBasel, Basel-Landschaft (Basle Country)
Founded
2010
Founded2010
Employees
11,000
Employees11,000

ONC Key Statistics

Market cap
46.90B
Market cap46.90B
Price-Earnings ratio
650.04
Price-Earnings ratio650.04
Dividend yield
—
Dividend yield—
Average volume
321.33K
Average volume321.33K
High today
$340.81
High today$340.81
Low today
$320.37
Low today$320.37
Open price
$329.29
Open price$329.29
Volume
665.08K
Volume665.08K
52 Week high
$385.22
52 Week high$385.22
52 Week low
$174.74
52 Week low$174.74

ONC News

TipRanks 3d
BeOne Medicines’ Combo Cancer Trial Reaches Completion: What Investors Should Watch Next

BeOne Medicines (ONC) announced an update on their ongoing clinical study. Claim 70% Off TipRanks Premium BeOne Medicines’ latest clinical update centers on a...

Analyst ratings

100%

of 29 ratings
Buy
100%
Hold
0%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.